Isabelle Chatelet-Du

Saint-maurice-en-valgodemard, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Decreases in influenza vaccination coverage among nursing home healthcare workers and in measures to promote influenza vaccination, France, 2007/08 to 2024/25.

Decreases in influenza vaccination coverage among nursing home healthcare workers and in measures to promote influenza vaccination, France, 2007/08 to 2024/25.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: May 16, 2026

Factors associated with an unfavorable outcome according to age in patients with COVID-19 admitted to intensive care in mainland France during the first three periods of the pandemic: a nationwide cohort study.

Factors associated with an unfavorable outcome according to age in patients with COVID-19 admitted to intensive care in mainland France during the first three periods of the pandemic: a nationwide cohort study.

Journal: Frontiers in medicine

Published: February 24, 2026

Investigation of a measles outbreak in a highly vaccinated middle school, France, 2023.

Investigation of a measles outbreak in a highly vaccinated middle school, France, 2023.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: November 21, 2025

Increase in invasive Haemophilus influenzae type b disease in young children despite high vaccination coverage, France, 2018-2024.

Increase in invasive Haemophilus influenzae type b disease in young children despite high vaccination coverage, France, 2018-2024.

Journal: Vaccine

Published: July 05, 2025

Clinical characteristics of cases during the 2024 pertussis epidemic in France, January 2024 to December 2024.

Clinical characteristics of cases during the 2024 pertussis epidemic in France, January 2024 to December 2024.

Journal: Vaccine

Published: October 17, 2024

Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018-2023.

Incidence, severity and treatment outcome of tuberculosis in the era of the COVID-19 pandemic, France, 2018-2023.

Journal: Journal of epidemiology and population health

Published: July 05, 2024

An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024.

An unusual outbreak of parvovirus B19 infections, France, 2023 to 2024.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: June 21, 2024

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

Effect of nirsevimab on hospitalisations for respiratory syncytial virus bronchiolitis in France, 2023-24: a modelling study.

Journal: The Lancet. Child & adolescent health

Published: March 09, 2024

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023-January 2024.

Nirsevimab Effectiveness Against Cases of Respiratory Syncytial Virus Bronchiolitis Hospitalised in Paediatric Intensive Care Units in France, September 2023-January 2024.

Journal: Influenza and other respiratory viruses

Published: March 07, 2024

History of smallpox vaccination and marked clinical expression of mpox among cases notified in France from May to July 2022.

History of smallpox vaccination and marked clinical expression of mpox among cases notified in France from May to July 2022.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: October 11, 2023

Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study.

Impact of vaccination against severe COVID-19 in the French population aged 50 years and above: a retrospective population-based study.

Journal: BMC medicine

Published: July 04, 2023

Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France.

Protection against symptomatic SARS-CoV-2 infection conferred by the Pfizer-BioNTech Original/BA.4-5 bivalent vaccine compared to the mRNA Original monovalent vaccines - A matched cohort study in France.

Journal: Vaccine

Published: April 07, 2023

Showing 1-12 of 34

Last Updated: 09/26/2026